AstraZeneca & Pfizer
10 shared events · Importance 4 · Last updated Aug 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
AstraZeneca: AstraZeneca is the central entity of the event; its breast cancer drug Etcamah failed a late-stage trial, sending its U.S.-listed shares down 3% in aftermarket trading. The setback is seen by analysts as manageable and largely anticipated, with the long-term investment case intact.
Pfizer: Pfizer's cancer drug Ibrance was the combination partner in the failed trial, but the negative readout is primarily attributed to AstraZeneca's Etcamah rather than to Ibrance itself.
Sep 11, 2026 · 6 articles
Business
AstraZeneca: AstraZeneca is the initiator of the merger talks, seeking to expand its US presence. Its shares fell over 7% on the news, reflecting investor skepticism about the deal's value and execution risk.
Pfizer: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
Business
AstraZeneca: AstraZeneca participated in the symposium, contributing to discussions on decarbonization and green chemistry.
Pfizer: Pfizer participated in the symposium, aligning with industry trends toward sustainable pharmaceutical manufacturing.
Jul 20, 2026 · 6 articles
Regulatory
AstraZeneca: AstraZeneca's flu vaccine portfolio could be affected by the entry of mFLUSIVA.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
Business
AstraZeneca: Investors punished the stock over merger talks with Bristol Myers Squibb.
Pfizer: Reported upbeat quarterly results, leading to a stock gain.
Jul 14, 2026 · 280 articles
Domestic
AstraZeneca: AstraZeneca's vaccine was previously suspended for under 60s in Germany in 2021 due to blood clot concerns; not directly affected by current policy.
Pfizer: Pfizer's COVID-19 vaccine (with BioNTech) may see reduced demand in Germany; the company has faced scrutiny over adverse event data.
Jul 13, 2026 · 6 articles
Business
AstraZeneca: AstraZeneca is mentioned as an existing AWS customer, but this event does not directly impact it.
Pfizer: Pfizer is mentioned as an existing AWS customer, but this event does not directly impact it.
Aug 10, 2026 · 7 articles
Business
AstraZeneca: AstraZeneca is a partner of Ascentage Pharma, but this event does not directly involve AstraZeneca.
Pfizer: Pfizer is a partner of Ascentage Pharma, but this event does not directly involve Pfizer.
Jul 26, 2026 · 6 articles
Regulatory
Pfizer: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how AstraZeneca and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard